300 related articles for article (PubMed ID: 3080584)
1. Altered pulmonary vascular smooth muscle responsiveness in monocrotaline-induced pulmonary hypertension.
Altiere RJ; Olson JW; Gillespie MN
J Pharmacol Exp Ther; 1986 Feb; 236(2):390-5. PubMed ID: 3080584
[TBL] [Abstract][Full Text] [Related]
2. alpha-Difluoromethylornithine, an inhibitor of polyamine synthesis, attenuates monocrotaline-induced pulmonary vascular hyperresponsiveness in isolated perfused rat lungs.
Gillespie MN; Dyer KK; Olson JW; O'Connor WN; Altiere RJ
Res Commun Chem Pathol Pharmacol; 1985 Dec; 50(3):365-78. PubMed ID: 3936139
[TBL] [Abstract][Full Text] [Related]
3. Na+/K(+)-adenosine triphosphatase activity of pulmonary arteries after intoxication with the pyrrolizidine alkaloid, monocrotaline.
Shubat PJ; Bowers RJ; Huxtable RJ
J Pharmacol Exp Ther; 1990 Jan; 252(1):70-6. PubMed ID: 2153811
[TBL] [Abstract][Full Text] [Related]
4. Changes in main pulmonary artery of rats with monocrotaline-induced pulmonary hypertension.
Guzowski DE; Salgado ED
Arch Pathol Lab Med; 1987 Aug; 111(8):741-5. PubMed ID: 3115224
[TBL] [Abstract][Full Text] [Related]
5. Endothelin and 5-hydroxytryptamine on rat pulmonary artery in pulmonary hypertension.
Wanstall JC; O'Donnell SR
Eur J Pharmacol; 1990 Feb; 176(2):159-68. PubMed ID: 2107090
[TBL] [Abstract][Full Text] [Related]
6. Inhaled tolafentrine reverses pulmonary vascular remodeling via inhibition of smooth muscle cell migration.
Pullamsetti S; Krick S; Yilmaz H; Ghofrani HA; Schudt C; Weissmann N; Fuchs B; Seeger W; Grimminger F; Schermuly RT
Respir Res; 2005 Nov; 6(1):128. PubMed ID: 16262900
[TBL] [Abstract][Full Text] [Related]
7. Ca2(+)-induced contraction and hyperreactivity of pulmonary arterial smooth muscle in monocrotaline-treated rats.
Takenaka T; Ogawa Y; Tobise K
Jpn Circ J; 1990 May; 54(5):515-23. PubMed ID: 2122039
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of phentolamine on the responsiveness of aortic and femoral smooth muscle from normotensive and DOCA/NaCl hypertensive rats.
Soltis EE; Soltis TD; Katovich MJ; Field FP
Artery; 1986; 13(6):325-39. PubMed ID: 3778217
[TBL] [Abstract][Full Text] [Related]
9. Polyamine content in pulmonary arteries from rats with monocrotaline-induced pulmonary hypertension.
Orlinska U; Olson JW; Gillespie MN
Res Commun Chem Pathol Pharmacol; 1988 Nov; 62(2):187-94. PubMed ID: 3150791
[TBL] [Abstract][Full Text] [Related]
10. Increased tail artery vascular responsiveness to angiotensin II in cold-treated rats.
Shechtman O; Sun Z; Fregly MJ; Katovich MJ
Can J Physiol Pharmacol; 1999 Dec; 77(12):974-9. PubMed ID: 10606444
[TBL] [Abstract][Full Text] [Related]
11. Potassium dependent relaxation of isolated pulmonary artery segments following ingestion of monocrotaline.
Shubat PJ; Huxtable RJ
Proc West Pharmacol Soc; 1988; 31():313-5. PubMed ID: 3145503
[No Abstract] [Full Text] [Related]
12. Pulmonary vasculature in monocrotaline-induced hypertensive rats on magnesium therapy.
Mathew R; Gloster ES; Altura BT; Altura BM
Microcirc Endothelium Lymphatics; 1990; 6(4-5):267-83. PubMed ID: 2149161
[TBL] [Abstract][Full Text] [Related]
13. Chloride channels and alpha1-adrenoceptor-mediated pulmonary artery smooth muscle contraction: effect of pulmonary hypertension.
Oriowo MA
Eur J Pharmacol; 2004 Dec; 506(2):157-63. PubMed ID: 15588736
[TBL] [Abstract][Full Text] [Related]
14. JTV-506, a new K(ATP) channel opener, relaxes pulmonary artery isolated from monocrotaline-treated pulmonary hypertensive rats.
Tsutsumi Y; Makita T; Yamaguchi K; Shibata O; Sumikawa K
J Anesth; 2004; 18(3):210-5. PubMed ID: 15290421
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of profilin, cofilin-2 and LIMK2 in cultured pulmonary artery smooth muscle cells and in pulmonary arteries of monocrotaline-treated rats.
Dai YP; Bongalon S; Tian H; Parks SD; Mutafova-Yambolieva VN; Yamboliev IA
Vascul Pharmacol; 2006 May; 44(5):275-82. PubMed ID: 16524786
[TBL] [Abstract][Full Text] [Related]
16. [Effects of various doses of monocrotaline administration on the development of pulmonary hypertension and its regression in rats].
Kakusaka I; Kaneko N; Kiyatake K; Fujita A; Suzuki A; Nakano K; Okada O; Sugita T; Watanabe S; Kuriyama T
Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Jan; 27(1):51-6. PubMed ID: 2501548
[TBL] [Abstract][Full Text] [Related]
17. Acetylcholine-induced contractions in isolated rabbit pulmonary arteries: role of thromboxane A2.
Altiere RJ; Kiritsy-Roy JA; Catravas JD
J Pharmacol Exp Ther; 1986 Feb; 236(2):535-41. PubMed ID: 3080588
[TBL] [Abstract][Full Text] [Related]
18. Antiremodeling effects of iloprost and the dual-selective phosphodiesterase 3/4 inhibitor tolafentrine in chronic experimental pulmonary hypertension.
Schermuly RT; Kreisselmeier KP; Ghofrani HA; Samidurai A; Pullamsetti S; Weissmann N; Schudt C; Ermert L; Seeger W; Grimminger F
Circ Res; 2004 Apr; 94(8):1101-8. PubMed ID: 15031263
[TBL] [Abstract][Full Text] [Related]
19. Altered artery mechanics and structure in monocrotaline pulmonary hypertension.
Langleben D; Szarek JL; Coflesky JT; Jones RC; Reid LM; Evans JN
J Appl Physiol (1985); 1988 Nov; 65(5):2326-31. PubMed ID: 3145283
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary vascular responses induced by the pyrrolizidine alkaloid, monocrotaline, in rats.
Shubat PJ; Banner W; Huxtable RJ
Toxicon; 1987; 25(9):995-1002. PubMed ID: 3124302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
